Characteristics of Hepatitis C Infection in Injecting Drug Users in Zadar County, Croatia

被引:0
作者
Medic, Alan [1 ]
Dzelalija, Boris [2 ]
Sonicki, Zdenko [3 ]
Zekanovic, Drazen [2 ]
机构
[1] Zadar Inst Publ Hlth, Zadar 23000, Croatia
[2] Zadar Gen Hosp, Zadar, Croatia
[3] Univ Zagreb, Sch Med, Andrija Stampar Sch Publ Hlth, Zagreb 41001, Croatia
关键词
heroin addiction; hepatitis C; injecting drug users; risk factors;
D O I
暂无
中图分类号
Q98 [人类学];
学科分类号
030303 ;
摘要
The aim of the study was to determine additional risk factors that could increase the prevalence of hepatitis C (HCV) infection among injecting drug users (IDU). The study included 327 heroin addicts registered in Zadar County, Croatia. The participants were divided into two groups according to their HCV status. HCV positive and HCV-negative study participants were compared. HCV-positive group started injecting heroin at earlier age (median 18.5 years) than HCV negative group (median 20.0 years) (p=0.032) and had been injecting heroin for a significantly longer period (median 5 years us. median 4 years, respectively; p<0.001). IDUs in HCV-positive group shared their injecting equipment significantly more often than IDUs in HCV-negative group (p<0.001; chi(2)=32.7). The main reasons for starting drugs were curiosity, psychological reasons (depression and/or neurosis), and peer or partner pressure in HCV-positive group, and fun, curiosity, and peer pressure in HCV-negative group (p=0.051; chi(2)=23.6). Earlier onset of heroin use, longer heroin use, sharing injection equipment, curiosity, and psychological problems as reasons for starting drugs were associated with higher prevalence of HCV infection among injecting heroin users in Zadar County.
引用
收藏
页码:697 / 702
页数:6
相关论文
共 46 条
  • [1] Seroprevalence of hepatitis C in a sample of middle class substance abusers
    Abraham, HD
    Degli-Esposti, S
    Marino, L
    [J]. JOURNAL OF ADDICTIVE DISEASES, 1999, 18 (04) : 77 - 87
  • [2] Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection
    Alric, L
    Fort, M
    Izopet, J
    Vinel, JP
    Charlet, JP
    Selves, J
    Puel, J
    Pascal, JP
    Duffaut, M
    Abbal, M
    [J]. GASTROENTEROLOGY, 1997, 113 (05) : 1675 - 1681
  • [3] Prevention of spread of hepatitis C
    Alter, MJ
    [J]. HEPATOLOGY, 2002, 36 (05) : S93 - S98
  • [4] [Anonymous], DRUG USE PREVENTION
  • [5] CHOA KC, 2000, W J MED, V172, P16
  • [6] A risk profile of street youth in Northern California: Implications for gender-specific human immunodeficiency virus prevention
    Clements, K
    Gleghorn, A
    Garcia, D
    Katz, M
    Marx, R
    [J]. JOURNAL OF ADOLESCENT HEALTH, 1997, 20 (05) : 343 - 353
  • [7] Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection
    ConryCantilena, C
    VanRaden, M
    Gibble, J
    Melpolder, J
    Shakil, AO
    Viladomiu, L
    Cheung, L
    DiBisceglie, A
    Hoofnagle, J
    Shih, JW
    Kaslow, R
    Ness, P
    Alter, HJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (26) : 1691 - 1696
  • [8] Epidemiology of hepatitis C virus infection among injecting drug users in Australia
    Crofts, N
    Jolley, D
    Kaldor, J
    van Beek, I
    Wodak, A
    [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1997, 51 (06) : 692 - 697
  • [9] Diaz T, 2001, AM J PUBLIC HEALTH, V91, P23, DOI 10.2105/AJPH.91.1.23
  • [10] DIENSTAG JL, 2005, PRINCIPLES PRACTICE